FDA Releases Draft Guidance on Cancer Treatments
Earlier this year, the United States Food and Drug Administration (FDA) released draft guidance, Real-Time Oncology Review (RTOR)…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Yearly Archives
2022
MGMA Requests “Appropriate Implementation Timeline” for No Surprises Act
On August 2, 2022, the Medical Group Management Association (MGMA) sent a letter to Xavier Becerra, Secretary of the Department of…
HHS OIG Finds Inaccuracies and Limitations in Medicare Enrollment Data
Earlier this year, the Department of Health and Human Services’ Office of Inspector General (HHS OIG) released a report showing…
House Passes Legislation to Extend Telehealth Reimbursement Flexibilities
On July 27, the House overwhelmingly passed legislation that would extend key telehealth reimbursement flexibilities through the…
Healthcare Implications of the Inflation Reduction Act
Congress officially passed the Inflation Reduction Act of 2022 (IRA). This comprehensive legislation is the result of many months…
CMS Releases Final Rule, Updating Payments to Hospitals
The Centers for Medicare and Medicaid Services released the final Inpatient Prospective Payment System (IPPS) and Long-Term Care…
HHS Wants to Reinterpret the Affordable Care Act, Healthcare Discrimination
On August 4, 2022, the US Department of Health and Human Services (HHS) issued a Notice of Proposed Rulemaking to reinterpret…
Where Are We on State Importation Plans?
In July 2022, Florida Governor Ron DeSantis hinted at potential litigation over the state’s Canadian drug import plan while at a…
DOJ Opens Criminal Probe into Cassava Sciences
In July 2022, Reuters exclusively reported that the United States Department of Justice (DOJ) opened a criminal investigation into…
Merck Sues HHS Over 340B Fines
The saga between the federal government and pharmaceutical companies over the 340B program continues to heat up. In July 2022,…